Although these chemotherapy agents provide convenience and ease, they are subject to hepatic first-pass metabolism and enzymatic drug-drug interactions.
Jeffrey Fudin, BS, PharmD, DAIPM, FCCP, FASHP, FFSMB
Advertisement
Articles by Jeffrey Fudin, BS, PharmD, DAIPM, FCCP, FASHP, FFSMB
Advertisement
Latest Updated Articles
Be Mindful of DDIs Between Analgesics and Oral Cancer DrugsPublished: April 26th 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
Less Common Pneumococcal Serotypes Cause More Severe Community-Acquired Pneumonia
3
Environmental Factors Could Influence Type 1 Diabetes Risk in Children Through Epigenetic Changes
4
FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma
5
